Biological Safety Cabinet Market

Biological Safety Cabinet Market by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic Research Institutes), and Region - Global Forecasts to 2027

Report Code: MD 6299 Oct, 2022, by marketsandmarkets.com

The global Biological Safety Cabinet Market boasts a total value of $0.2 billion in 2022 and is projected to register a growth rate of 8.2% to reach a value of $0.4 billion by 2027. Market growth is driven by the increased research in pharmaceutical industry and rapid growth in vaccine development for communicable diseases.

Biological Safety Cabinet Market

e-estimated, p-projected

To know about the assumptions considered for the study, Request for Free Sample Report

Biological Safety Cabinet Market Dynamics

Drivers: Favorable regulations

Increased government regulations on healthcare industries specifically focused on safety are increased significantly. Due to the increased demand of high quality healthcare products pharmaceutical and biopharmaceutical companies have increased the use of biological safety cabinets. These regulatory requirements for the use of biological safety cabinets will drive the mrket growth.

Opportunities: Emerging market offers lucrative growth opportunities

There is an increase in funding and increased R&D expenditure offered by government and private institutions is expected to offer significant growth opportunities. The pharmaceutical industry in the emerging market invest heavily in drug development, the growing demand for new drug molecules offer great opportunity for biological safety cabinets.

Restraints: Alternative containment cabinets

There is significant increase in the development of efficient and reliable alternatives of the biosafety cabinets. These devices provide better sterility as compared to biosafety cabinets and are majorly used in pharmaceutical and biopharmaceutical companies.

In 2021, class II segment accounted for the largest share of the biological safety cabinet market, by type

The biological safety cabinet market is segmented into class I, class II and class III. The class II segment accounted for the largest share of the biological safety cabinet market in 2021, mainly due to the rising investment for development of new drug molecules.

In 2021, pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the biological safety cabinet market, by end user

The biological safety cabinet market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and testing laboratories and academic research institutes based on end user. In 2021, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share. Factors such as increased need of biologics leads to market growth.

North America is the largest regional market for biological safety cabinet market

The global biological safety cabinet market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the global biological safety cabinet market. The North American biological safety cabinet market's growth can be attributed to the increase in communicable diseases.

Biological Safety Cabinet Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Biological Safety Cabinet Market Key Players

Scope of the Biological Safety Cabinet Market Report

Report Metrics

Details

Market Size value 2027

USD 0.4 billion

Growth Rate

8.2% Compound Annual Growth Rate (CAGR)

Largest Market

North America

Market Dynamics

Drivers, Opportunities, Restraints & Challenges

Largest Share Segments

  • Based on type - The class II segment accounted for the largest share
  • Based on End User - Pharmaceutical and biopharmaceutical companies segment to register the highest growth rate

Table of Content

  • 107 Market data Tables
  • 33 Figures
  • 160 Pages

Market Segmentation

By Type, End User and Region

Biological Safety Cabinet Market Growth Drivers

Increased favorable government regulations on healthcare industries

Biological Safety Cabinet Market Growth Opportunities

Emerging market offers lucrative growth opportunities

Report Highlights

  • Updated financial information/ product portfolio of players
  • Updated market developments of profiled players

Geographies Covered

North America, Europe, APAC, MEA, and Latin America

This report categorizes the global biological safety cabinet market into the following segments and subsegments:

By Type

  • Class I
  • Class II
  • Class III

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Diagnostic and Testing Laboratories
  • Academic Research Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In May 2021, Labconco (US) launched newly updated axiom biosafety cabinets.
  • In December 2020, Labconco (US) unveiled a 65% larger class II enclosure uniquely designed for lab instrumentation.
  • In May 2019, Labconco (US) unveiled updated logic+ biosafety cabinets with exclusive features for safety, ergonomics, and an updated operating system.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 22)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKETS COVERED
           1.3.1 BIOLOGICAL SAFETY CABINETS MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 26)
    2.1 RESEARCH DATA
    2.2 RESEARCH APPROACH
          FIGURE 1 BIOLOGICAL SAFETY CABINETS MARKET: RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    2.2.2.1 Primary sources
                    2.2.2.2 Key data from primary sources
                    2.2.2.3 Key industry insights
                    2.2.2.4 Breakdown of primary interviews
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION
           2.3.1 BOTTOM-UP APPROACH
                    2.3.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    2.3.1.2 Approach 2: Presentations of companies and primary interviews
                    2.3.1.3 CAGR projections
                                FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.3.2 TOP-DOWN APPROACH
                    FIGURE 6 BIOLOGICAL SAFETY CABINETS MARKET: TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ANALYSIS
    2.6 STUDY ASSUMPTIONS
    2.7 GROWTH RATE ASSUMPTIONS
    2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 37)
    FIGURE 8 BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 40)
    4.1 BIOLOGICAL SAFETY CABINETS MARKET OVERVIEW
          FIGURE 11 INCREASED RISK OF PANDEMICS AND COMMUNICABLE DISEASES TO DRIVE MARKET
    4.2 BIOLOGICAL SAFETY CABINETS MARKET SHARE, BY TYPE, 2022 VS. 2027
          FIGURE 12 CLASS II SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
    4.3 BIOLOGICAL SAFETY CABINETS MARKET SHARE, BY END USER, 2022 VS. 2027
          FIGURE 13 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES—LARGEST END USERS OF BIOLOGICAL SAFETY CABINETS
    4.4 BIOLOGICAL SAFETY CABINETS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 14 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH IN FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 43)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 15 BIOLOGICAL SAFETY CABINETS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           5.2.1 DRIVERS
                    5.2.1.1 Favorable regulations
                    5.2.1.2 Increased risk of pandemics and communicable diseases
                    5.2.1.3 Increasing number of R&D activities in pharmaceutical and biopharmaceutical companies
                                FIGURE 16 R&D SPENDING BY PHRMA MEMBER COMPANIES, 2001–2019 (USD BILLION)
                                TABLE 1 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2019 VS. 2026 (USD BILLION)
                    5.2.1.4 Rapid growth in biologics
                                FIGURE 17 TOTAL NUMBER OF NEW BIOLOGICS LICENSE APPLICATION APPROVALS, NDA APPROVALS, AND FILINGS (2005–2019)
                                TABLE 2 US: LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS, 2019
                    5.2.1.5 Growing concerns over cell culture contamination
           5.2.2 RESTRAINTS
                    5.2.2.1 Alternative containment cabinets
                    5.2.2.2 High cost of biological safety cabinets
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets offer lucrative growth opportunities
    5.3 PRICING ANALYSIS
          TABLE 3 PRICE OF BIOLOGICAL SAFETY CABINETS (2021)
    5.4 PATENT ANALYSIS
          FIGURE 18 PATENT ANALYSIS OF BIOLOGICAL SAFETY CABINETS MARKET
           5.4.1 LIST OF MAJOR PATENTS
    5.5 VALUE CHAIN ANALYSIS
          FIGURE 19 VALUE CHAIN ANALYSIS OF BIOLOGICAL SAFETY CABINETS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.6 SUPPLY CHAIN ANALYSIS
          FIGURE 20 BIOLOGICAL SAFETY CABINETS MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM/MARKET MAP
          FIGURE 21 BIOLOGICAL SAFETY CABINETS MARKET: ECOSYSTEM/MARKET MAP
          TABLE 4 BIOLOGICAL SAFETY CABINETS MARKET: ROLE IN ECOSYSTEM
    5.8 PORTER’S FIVE FORCES ANALYSIS
          TABLE 5 BIOLOGICAL SAFETY CABINETS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF BUYERS
           5.8.4 BARGAINING POWER OF SUPPLIERS
           5.8.5 DEGREE OF COMPETITION
    5.9 REGULATORY LANDSCAPE
          TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.10 TRADE ANALYSIS
           5.10.1 TRADE ANALYSIS FOR LABORATORY MACHINERY AND EQUIPMENT
                    TABLE 11 IMPORT DATA FOR LABORATORY MACHINERY AND EQUIPMENT, BY COUNTRY, 2017–2021 (USD MILLION)
                    TABLE 12 EXPORT DATA FOR LABORATORY MACHINERY AND EQUIPMENT, BY COUNTRY, 2017–2021 (USD MILLION)
    5.11 TECHNOLOGY ANALYSIS
    5.12 KEY CONFERENCES AND EVENTS IN 2022–2023
            TABLE 13 BIOLOGICAL SAFETY CABINETS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.13.1 REVENUE SOURCES SHIFTING TOWARD TECHNOLOGY-BASED SOLUTIONS DUE TO COVID-19
                     FIGURE 22 REVENUE SHIFT IN BIOLOGICAL SAFETY CABINETS MARKET
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOLOGICAL SAFETY CABINET PRODUCTS
                     TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOLOGICAL SAFETY CABINETS (%)
           5.14.2 BUYING CRITERIA
                     FIGURE 24 KEY BUYING CRITERIA FOR BIOLOGICAL SAFETY CABINETS
                     TABLE 15 KEY BUYING CRITERIA FOR BIOLOGICAL SAFETY CABINETS
    5.15 CASE STUDIES
           5.15.1 CASE STUDY: LABORATORY BIOLOGICAL SAFETY CABINET (BSC) EXPLOSION

6 BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE (Page No. - 66)
    6.1 INTRODUCTION
          TABLE 16 BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 17 BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (THOUSAND UNITS)
    6.2 CLASS I
           6.2.1 GOVERNMENT INITIATIVES TO DRIVE MARKET
                    TABLE 18 CLASS I BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.3 CLASS II
          TABLE 19 CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 20 CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.1 CLASS II TYPE A
                    6.3.1.1 Increased usage of Class II Type A biosafety cabinets in laboratories to support market growth
                                TABLE 21 CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.2 CLASS II TYPE B
                    6.3.2.1 Class II Type B cabinets used for volatile and toxic chemicals
                                TABLE 22 CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 CLASS III
           6.4.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
                    TABLE 23 CLASS III BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2020–2027 (USD MILLION)

7 BIOLOGICAL SAFETY CABINETS MARKET, BY END USER (Page No. - 73)
    7.1 INTRODUCTION
                    TABLE 24 BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
           7.2.1 INCREASING R&D EXPENDITURE ENABLES COMPANIES TO INVEST IN HIGH-END BIOSAFETY CABINETS
          TABLE 25 BIOLOGICAL SAFETY CABINETS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION)
    7.3 DIAGNOSTIC AND TESTING LABORATORIES
           7.3.1 RISING PREVALENCE OF DISEASES TO SUPPORT MARKET GROWTH
          TABLE 26 BIOLOGICAL SAFETY CABINETS MARKET FOR DIAGNOSTIC AND TESTING LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
    7.4 ACADEMIC RESEARCH INSTITUTES
           7.4.1 INCREASING NUMBER OF RESEARCH ACTIVITIES AND RISING GOVERNMENT FUNDING FOR MEDICAL RESEARCH TO SUPPORT MARKET GROWTH
                    TABLE 27 BIOLOGICAL SAFETY CABINETS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)

8 BIOLOGICAL SAFETY CABINETS MARKET, BY REGION (Page No. - 78)
    8.1 INTRODUCTION
          TABLE 28 BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.2 NORTH AMERICA
          FIGURE 25 NORTH AMERICA: BIOLOGICAL SAFETY CABINETS MARKET SNAPSHOT
          TABLE 29 NORTH AMERICA: BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 30 NORTH AMERICA: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 31 NORTH AMERICA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 32 NORTH AMERICA: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.2.1 US
                    8.2.1.1 Growth in biosimilars market to boost preclinical research
                                TABLE 33 US: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 34 US: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 35 US: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.2.2 CANADA
                    8.2.2.1 Government support for R&D to support market growth
                                TABLE 36 CANADA: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 37 CANADA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 38 CANADA: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.3 EUROPE
          TABLE 39 EUROPE: BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 40 EUROPE: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 41 EUROPE: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 42 EUROPE: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.3.1 GERMANY
                    8.3.1.1 Increased funding and growth of research sector to drive market
                                TABLE 43 GERMANY: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 44 GERMANY: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 45 GERMANY: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.3.2 UK
                    8.3.2.1 Increasing awareness about safety in high-risk environments to propel market
                                TABLE 46 UK: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 47 UK: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 48 UK: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.3.3 FRANCE
                    8.3.3.1 Growing healthcare industry to provide growth opportunities
                                TABLE 49 FRANCE: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 50 FRANCE: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 51 FRANCE: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.3.4 REST OF EUROPE
                    TABLE 52 REST OF EUROPE: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 53 REST OF EUROPE: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 54 REST OF EUROPE: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.4 ASIA PACIFIC
          FIGURE 26 ASIA PACIFIC: BIOLOGICAL SAFETY CABINETS MARKET SNAPSHOT
                    TABLE 55 ASIA PACIFIC: BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 56 ASIA PACIFIC: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 57 ASIA PACIFIC: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 58 ASIA PACIFIC: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.4.1 JAPAN
                    8.4.1.1 Largest market for biological safety cabinets in Asia Pacific
                                TABLE 59 JAPAN: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 60 JAPAN: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 61 JAPAN: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.4.2 CHINA
                    8.4.2.1 Government initiatives in drug development to support market growth
                                TABLE 62 CHINA: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 63 CHINA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 64 CHINA: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.4.3 INDIA
                    8.4.3.1 Growing pharmaceutical industry to drive market
                                TABLE 65 INDIA: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 66 INDIA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 67 INDIA: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.4.4 REST OF ASIA PACIFIC
                    TABLE 68 REST OF ASIA PACIFIC: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 69 REST OF ASIA PACIFIC: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 70 REST OF ASIA PACIFIC: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.5 LATIN AMERICA
           8.5.1 FAVORABLE GOVERNMENT POLICIES AND INCREASING DEMAND FOR NEW DRUG MOLECULES—KEY FACTORS DRIVING MARKET
                    TABLE 71 LATIN AMERICA: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 72 LATIN AMERICA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 73 LATIN AMERICA: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.6 MIDDLE EAST AND AFRICA
           8.6.1 INCREASING R&D INVESTMENTS AND FOCUS ON DEVELOPMENT OF NEW DRUGS TO DRIVE MARKET
                    TABLE 74 MIDDLE EAST AND AFRICA: BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 75 MIDDLE EAST AND AFRICA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 76 MIDDLE EAST AND AFRICA: BIOLOGICAL SAFETY CABINETS MARKET, BY END USER, 2020–2027 (USD MILLION)

9 COMPETITIVE LANDSCAPE (Page No. - 108)
    9.1 OVERVIEW
    9.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
           9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BIOLOGICAL SAFETY CABINETS MARKET
                    TABLE 77 OVERVIEW OF STRATEGIES ADOPTED BY KEY BIOLOGICAL SAFETY CABINET MANUFACTURING COMPANIES
    9.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
          FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN BIOLOGICAL SAFETY CABINETS MARKET
    9.4 MARKET SHARE ANALYSIS
          FIGURE 28 BIOLOGICAL SAFETY CABINETS MARKET SHARE, BY KEY PLAYER (2021)
          TABLE 78 BIOLOGICAL SAFETY CABINETS MARKET: DEGREE OF COMPETITION
    9.5 COMPANY EVALUATION QUADRANT
           9.5.1 LIST OF EVALUATED VENDORS
           9.5.2 STARS
           9.5.3 EMERGING LEADERS
           9.5.4 PERVASIVE PLAYERS
           9.5.5 PARTICIPANTS
                    FIGURE 29 BIOLOGICAL SAFETY CABINETS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
    9.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021)
           9.6.1 PROGRESSIVE COMPANIES
           9.6.2 STARTING BLOCKS
           9.6.3 RESPONSIVE COMPANIES
           9.6.4 DYNAMIC COMPANIES
                    FIGURE 30 BIOLOGICAL SAFETY CABINETS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
    9.7 COMPETITIVE BENCHMARKING
           9.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS
                    FIGURE 31 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BIOLOGICAL SAFETY CABINETS MARKET
                    TABLE 79 BIOLOGICAL SAFETY CABINETS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
                    TABLE 80 PRODUCT FOOTPRINT OF COMPANIES
                    TABLE 81 REGIONAL FOOTPRINT OF COMPANIES
                    TABLE 82 BIOLOGICAL SAFETY CABINETS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    9.8 COMPETITIVE SCENARIO
           9.8.1 PRODUCT LAUNCHES
                    TABLE 83 KEY PRODUCT LAUNCHES

10 COMPANY PROFILES (Page No. - 118)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     10.1 KEY PLAYERS
             10.1.1 THERMO FISHER SCIENTIFIC
                        TABLE 84 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
             10.1.2 KEWAUNEE SCIENTIFIC
                        TABLE 85 KEWAUNEE SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 33 KEWAUNEE SCIENTIFIC: COMPANY SNAPSHOT (2021)
             10.1.3 LABCONCO
                        TABLE 86 LABCONCO: BUSINESS OVERVIEW
             10.1.4 ESCO MICRO
                        TABLE 87 ESCO MICRO: BUSINESS OVERVIEW
             10.1.5 THE BAKER COMPANY
                        TABLE 88 THE BAKER COMPANY: BUSINESS OVERVIEW
             10.1.6 NUAIRE
                        TABLE 89 NUAIRE: BUSINESS OVERVIEW
             10.1.7 GERMFREE LABORATORIES
                        TABLE 90 GERMFREE LABORATORIES: BUSINESS OVERVIEW
             10.1.8 CRUMA
                        TABLE 91 CRUMA: BUSINESS OVERVIEW
             10.1.9 AIR SCIENCE
                        TABLE 92 AIR SCIENCE: BUSINESS OVERVIEW
             10.1.10 BERNER INTERNATIONAL
                        TABLE 93 BERNER INTERNATIONAL: BUSINESS OVERVIEW
             10.1.11 AZBIL TELSTAR
                        TABLE 94 AZBIL TELSTAR: BUSINESS OVERVIEW
             10.1.12 LABOGENE
                        TABLE 95 LABOGENE: BUSINESS OVERVIEW
             10.1.13 BIOLAB SCIENTIFIC
                        TABLE 96 BIOLAB SCIENTIFIC: BUSINESS OVERVIEW
             10.1.14 LAMSYSTEMS GMBH
                        TABLE 97 LAMSYSTEMS GMBH: BUSINESS OVERVIEW
             10.1.15 FASTER S.R.L.
                        TABLE 98 FASTER S.R.L.: BUSINESS OVERVIEW
     10.2 OTHER PLAYERS
             10.2.1 MRC LABORATORY EQUIPMENT
                        TABLE 99 MRC LABORATORY EQUIPMENT: COMPANY OVERVIEW
             10.2.2 NANBEI INSTRUMENT LIMITED
                        TABLE 100 NANBEI INSTRUMENT LIMITED: COMPANY OVERVIEW
             10.2.3 THERMOLAB
                        TABLE 101 THERMOLAB: COMPANY OVERVIEW
             10.2.4 LABMATE
                        TABLE 102 LABMATE: COMPANY OVERVIEW
             10.2.5 TOPAIR SYSTEMS, INC.
                        TABLE 103 TOPAIR SYSTEMS, INC.: COMPANY OVERVIEW
             10.2.6 ALBIAN GROUP
                        TABLE 104 ALBIAN GROUP: COMPANY OVERVIEW
             10.2.7 THOMAS SCIENTIFIC
                        TABLE 105 THOMAS SCIENTIFIC: COMPANY OVERVIEW
             10.2.8 ZHEJIANG FUXIA MEDICAL TECHNOLOGY CO., LTD.
                        TABLE 106 ZHEJIANG FUXIA MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
             10.2.9 STERICOX
                        TABLE 107 STERICOX: COMPANY OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

11 APPENDIX (Page No. - 154)
     11.1 DISCUSSION GUIDE
     11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.3 CUSTOMIZATION OPTIONS
     11.4 RELATED REPORTS
     11.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the biological safety cabinet market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

The following is a breakdown of the primary respondents:

Biological Safety Cabinet Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the biological safety cabinet market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the biological safety cabinet market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Biological Safety Cabinet Market Size: Top-Down Approach

Biological Safety Cabinet Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the biological safety cabinet market by type, end user and region.
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints and opportunities).
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa,
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2.
  • To track and analyze company developments such as product launches in the biological safety cabinet market.
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Biological safety cabinet market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa.

Company profiles

  • Product portfolio matrix for leading market players.
Report Code
MD 6299
Published ON
Oct, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biological Safety Cabinet Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback